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Abstract
Background/Aim. Recurrent vulvovaginal candidiasis is
relatively frequent condition, and may have serious health
consequences, like chronic vulvovaginal pain syndrome.
The aim of our study was to determine possible risk fac-
tors for recurrent vulvovaginal candidiasis in non-pregnant
females within the reproductive age. Methods. The design
of our study was of a case-control type. Case and control
patients were selected from the gynecological patients at
six primary care facilities in Serbia and in Montenegro.
The data on the patients’ health condition, concomitant
therapy and diseases were taken from their records, and
the data on habits were obtained by unstructured inter-
view. For potential risk factors crude odds ratios were cal-
culated, and then adjusted by logistic regression. Results.
A total of fifty-one patients had four or more episodes of
vulvovaginal candidiasis during the last year (cases), and
132 patients with one to three episodes of vulvovaginal
candidiasis were sampled as controls, matched by age. The
only two significant associations were found between re-
current vulvovaginal candidiasis and continual wearing of
panty liners during the last year (Odds ratio – ORadjusted:
3.97; confidence interval – CI: 1.57–10.02; p = 0.004), and
between recurrent vulvovaginal candidiasis and predomi-
nant use of vaginal tampons during menstruation in the
last year (ORadjusted: 4.25; CI: 1.11–16.27; p = 0.035). The
synergistic effect was observed for the concurrent contin-
ual wearing of panty liners during the last year and self-
medication with antimycotics. Conclusions. Local factors,
like wearing of panty liners or use of tampons during
menstruation, may promote recurrence of vulvovaginal
candidiasis, especially in patients who practice self-
medication with antimycotics.
Key words:
candidiasis, vulvovaginal; recurrence; risk factors; risk;
data interpretation, statistical.
Apstrakt
Uvod/Cilj.  Rekurentna vulvovaginalna kandidijaza je često
zdravstveno stanje koje može da ima i ozbiljne posledice, kao
što je sindrom hroničnog vulvovaginalnog bola. Cilj ove stu-
dije bio je da se utvrde faktori rizika od nastanka rekurentne
vulvovaginalne kandidijaze kod negravidnih žena u reproduk-
tivnom periodu. Metode. U našoj studiji tipa case-control uče-
stvovale su ginekološke bolesnice iz šest ustanova primarne
zdravstvene zaštite Republike Srbije i Republike Crne Gore.
Podaci o zdravstvenom stanju, stanju bolesti i pratećoj terapiji
bolesnica prikupljeni su iz njihovih zdravstvenih kartona, dok
su podaci o navikama dobijeni nestrukturisanim intervjuom.
Značaj potencijalnih faktora rizika prvo je pojedinačno pro-
cenjivan neprilagođenim unakrsnim odnosom, da bi zatim, uz
pomoć binarne logističke regresije, unakrsni odnos bio prila-
gođen za istovremeno dejstvo više faktora. Rezultati. Grupa
od 51 bolesnice  imala je četiri ili više od četiri epizoda vulvo-
vaginalne kandidijaze tokom protekle godine, dok su 132 bo-
lesnice kontrolne grupe imale po jednu do tri epizode u istom
periodu (grupe su bile usklađene po životnom dobu). Utvr-
đena je značajna povezanost između rekurentne vulvovagi-
nalne kandidijaze i kontinuiranog nošenja dnevnih uložaka
tokom proteklih godinu dana [dds-ratio (OR)adjusted = 3,97; in-
terval poverenja (CI) = 1,57–10,02; p = 0,004)], kao i između
rekurentne vulvovaginalne kandidijaze i predominantne upot-
rebe vaginalnih tampona tokom menstruacije u proteklih go-
dinu dana [ORadjusted = 4,25; CI = 1,11–16,27; p = 0,035]. Za-
paženo je da istovremeno kontinualno nošenje dnevnih ulo-
žaka tokom poslednjih godinu dana i samomedikacija antimi-
koticima dodatno povećavaju sklonost nastanku rekurentne
vulvovaginalne kandidijaze. Zakljak. Lokalni faktori, kao što
su nošenje dnevnih uložaka ili upotreba tampona tokom
menstruacije, doprinose recidivu vulvovaginalne kandidijaze,
pogotovo kod bolesnica koje praktikuju samomedikaciju an-
timikoticima.
Ključne reči:
kandidijaza, vulvovaginalna; recidiv; faktori rizika;
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Introduction
Vulvovaginal candidiasis is an inflammation of the va-
gina and vulva caused by Candida albicans (46.9–75%), or
one of other Candida  species:  Candidia glabrata (14–
36.7%), Candidia parapsilosis (10.2%), Candidia tropicalis
(2.8–7%), Candidia krusei (1.4–3.5%), and Candidia kiefer
(1.9%)
1, 2. Prevalence of symptomatic vulvovaginal candidia-
sis among the patients of gynecology clinics is around 8% 
3,
and vaginal carriers of these fungal species are encountered
in as often as 27% of cases 
4.
The patients who experience more than three attacks of
vulvovaginitis caused by Candida species during the last
year or have previous disease history longer than one year
are classified as patients with recurrent vulvovaginal candi-
diasis 
5, 6. Recurrent vulvovaginal candidiasis is relatively
frequent (around 8.5% in patients with symptomatic vulvo-
vaginal candidiasis) 
7, and may have serious health conse-
quences, like chronic vulvovaginal pain syndrome 
8.
There are many risk factors for development of vulvo-
vaginal candidiasis 
7, like advanced reproductive age, preg-
nancy, diabetes, hormonal contraception 
9, recent antibiotic use,
dietary practices, gastrointestinal colonization by the organism,
clothing and sanitary protection practices, sexual communica-
bility of the organism, and specific immunological defects 
10.
However, risk factors for recurrent vulvovaginal candidiasis are
somewhat different, and not yet established with certainty.
Stress 
11, use of panty liners or pantyhose, consumption of
cranberry juice or acidophil-containing products, a history of
bacterial vaginosis, steroid therapy, diabetes mellitus, age < 40
years and abnormal local host response to Candida 
12 were
positively associated with recurrent vulvovaginal candidiasis 
13,
14, but this association was not confirmed in more than one
study and the pathophysiology of chronic,
 recurrent vulvovagi-
nal candidiasis remains unclear 
15. Some studies did not con-
firm these risk factors at all, but only pointed to the importance
of hormonal contraception, frequency of sexual intercourses
and technique of vulvovaginal hygiene 
16.
The aim of our study was to determine association of
previously investigated and some new risk factors with re-
current vulvovaginal candidiasis in non-pregnant females
within the reproductive age, and therefore resolve controver-
sies made by opposing results of previous studies.
Methods
Our study was conducted in six primary care gyneco-
logical dispensaries in Serbia and Montenegro, located in six
cities: Belgrade, Jagodina, Kragujevac, Novi Pazar, Uzice (in
Serbia) and Podgorica (in Montenegro), covering population
of approximately 800 000 inhabitants. The source population
of our study consisted of all consecutive patients in repro-
ductive age with vulvovaginal candidiasis (microbiologically
proved) who visited gynecological dispensaries (n = 804)
during one-month period, from March 1
st, 2009, to March
31
st, 2009. Data on drug prescription and (co)morbidity were
obtained from medical records. Data on non-prescription
drugs use and habits were obtained by unstructured interview
with the patients. All data were kept anonymous, with previ-
ous consent of the patients, and the study protocol was ap-
proved by Ethics Committee of the School of Medicine,
University of Kragujevac, empowered to make decisions on
clinical studies in six primary care facilities.
The design of the study was of a case-control type, with
the aim to assess the relationship between potential risk fac-
tors and occurrence of recurrent vulvovaginal candidiasis
(more than three episodes during the previous year) in pa-
tients within reproductive age. The case and control patients
(study population) were selected from the gynecological ex-
amination records made during the study period, at the study
primary care facilities. Pregnant and lactating patients, pa-
tients of pre-menarche and post-menopause age were ex-
cluded from the study.
The cases were chosen from the study population if
they experienced more than three episodes of vulvovaginal
candidiasis during the last year. Vulvovaginal candidiasis
episode was defined as simultaneous existence of two out of
three following criteria: 1) isolation of Candida species from
culture of vaginal smear; 2) detection of Candida species on
potassium hydroxide (KOH) preparation of vaginal smear;
and 3) clinical diagnosis made by a gynecologist working in
the study primary care facilities. Recurrent episodes were
considered and calculated as new events if the patients were
previously treated with appropriate antimycotics, and if at
least 30 days elapsed from the achieved clinical resolution of
symptoms in a previous episode. The case patients were
counted only once, even if they had more than one visit to
the gynecological dispensary during the study period.
For each case, at least two age-matched control patients
were randomly selected from the source population. The con-
trol patients were defined as those patients with one to three
episodes of vulvovaginal candidiasis during the last year.
In order to identify risk factors and potential con-
founders, the following data on status, habits, (co)medication
and (co)morbidity were collected for each patient: age, body
mass index, existence of diabetes mellitus type 1 or 2; anti-
biotic use during seven or more days within the last month;
systemic use of corticosteroids for at least 15 days in the last
15 months; continual wearing of panty liners during the last
year; wearing of tight clothes during 90% of time in the last
year; predominant wearing of underwear made from syn-
thetic fabric; predominant wearing of lace thong underwear
during the last year; predominant use of vaginal tampons
during menstruation in the last year; use of immunosuppres-
sive drugs for at least one month during the last year; the
presence of intrauterine contraceptive device during at least 6
months in the last year; the rate of sexual intercourses during
the last year; the use of hormonal contraceptives during at
least 6 months before enrollment to the study; exposure to
training in vaginal irrigation offered by health workers;
smoking (more than 5 cigarettes daily during the last year);
bacteria in vaginal smear confirmed at least once during the
last year; concomitant chronic non-contagious disease except
diabetes mellitus; self-medication with antimycotics (without
being prescribed by a physician) during the last year; serious
event causing stress during the last year (divorce, death of aVolumen 67, Broj 10 VOJNOSANITETSKI PREGLED Strana 821
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first-line relative, loss of job or change of a place of living);
concomitant hypothyreosis or hyperthyreosis; employment
status; regular daily intake of coffee during the last year;
previous hysterectomy; sedentary job during the last year; al-
cohol intake per week during the last year; average weekly
intake of fermented milk products during the last year; level
of education; number of irregular periods during the last
year; average duration of menstrual bleeding and religion
(Christian, Muslim or Atheist).
The prevalence of each characteristic during the last 3
years was determined for both cases and controls. The differ-
ences between cases and controls in the observed characteris-
tics were assessed by a Student's t test for continuous variables
and a χ
2 test for frequencies. The differences were considered
significant if probability of null hypothesis was less than 0.05.
In order to estimate the association between independent vari-
ables and recurrent vulvovaginal candidiasis crude and ad-
justed odds ratios (OR) with 95% confidence intervals (95%
CI) were calculated using logistic regression 
17, 18.
Results
A total number of patients with vulvovaginal candidia-
sis in the six gynecological dispensaries during the study pe-
riod was 804. Fifty-one patients had four or more episodes of
vulvovaginal candidiasis during the last year (cases), and 132
patients with one to three episodes of vulvovaginal candidia-
sis were sampled as controls, matched by age. Significant
differences between cases and controls were observed in:
antibiotic use during seven or more days within the last
month (χ
2 = 3.877; p = 0.049; OR = 1.97; CI = 0.98–3.94),
continual wearing of panty liners during the last year (χ
2 =
13.131; p = 0.0001; OR = 3.23; CI = 1.68–6.22), predomi-
nant use of vaginal tampons during menstruation in the last
year (χ
2 = 6.467; p = 0.011; OR = 3.25; CI = 1.24–8.50) and
self-medication with antimycotics (χ 
2 = 4.055; p = 0.044;
OR = 1.95; CI = 1.00–3.83) (Table 1).
Table 1
Baseline characteristics of cases and controls
Variable Cases
(n = 51)
Controls
(n = 132)
Test value and
significance of null
hypothesis
Crude odds ratios with confidence
intervals (1.96 SE)
Age (years) 32.7 ± 7.0 34.5 ± 9.4 T = -1.376, p = 0.171 N/A
BMI (kg/m
2) 22.3 ± 3.1 23.2 ± 3.7 T = -1.684, p = 0.095 N/A
Concomitant diabetes 2 (4%) 2 (2%) χ 
2 = 0.189, p = 0.664 2.60 (0.36–18.92)
Antibiotic use, 7 days
in the last month 18 (35%) 28 (21%) χ 
2 = 3.877, p = 0.049* 1.97 (0.98–3.94)
Corticosteroids use 5 (10%) 6 (5%) χ 
2 = 0.990, p = 0.320 2.23 (0.65–7.64)
Panty liners 28 (54%) 35 (27%) χ 
2 = 13.131, p = 0.000* 3.23 (1.68–6.22)
Tight clothes 24 (46%) 45 (34%) χ 
2 = 2.634, p = 0.105 1.66 (0.88-3.13)
Synthetic underwear 11 (21%) 27 (20%) χ 
2 = 0.028, p = 0.868 1.04 (0.48–2.27)
Lace thong underwear 8 (16%) 15 (11%) χ 
2 = 0.626, p = 0.429 1.42 (0.57–3.55)
Vaginal tampons 10 (20%) 9 (7%) χ 
2 = 6.467, p = 0.011* 3.25 (1.24–8.50)
Immunosuppressive drugs 1 (2%) 6 (5%) χ 
2 = 0.150, p = 0.698 0.41 (0.05–3.50)
Intrauterine contraceptive
device 1 (2%) 6 (5%) χ 
2 = 0.150, p = 0.698 0.41 (0.05–3.50)
Rate of sexual intercourses per
week 1.4 ± 1.2 1.5 ± 1.4 T = -0.567, p = 0.571 N/A
Oral contraceptives 5 (10%) 3 (2%) χ 
2 = 3.352, p = 0.067 3.58 (0.78–16.55)
Vaginal irrigation training 14 (27%) 38 (29%) χ 
2 = 0.032, p = 0.857 0.91 (0.45–1.84)
Smoking 21 (41%) 52 (39%) χ 
2 = 0.049, p = 0.825 0.89 (0.47–1.68)
Bacterial vaginosis 21 (41%) 45 (34%) χ 
2 = 0.801, p = 0.371 1.31 (0.70–2.49)
Chronic disease 6 (12%) 13 (10%) χ 
2 = 0.145, p = 0.703 1.19 (0.43–3.31)
Self-medication with
antimycotics 20 (39%) 32 (24%) χ 
2 = 4.055, p = 0.044* 1.95 (1.00–3.83)
Stressful event 17 (33%) 31 (23%) χ 
2 = 1.844, p = 0.174 1.52 (0.76–3.03)
Thyroid dysfunction 2 (4%) 4 (3%) χ 
2 = 0.092, p = 0.761 1.28 (0.23–7.19)
Unemployed 29 (57%) 73 (55%) χ 
2 = 0.036, p = 0.849 1.02 (0.55–1.88)
Regular daily intake of coffee 47 (92%) 122 (92%) χ 
2 = 0.004, p = 0.951 0.98 (0.35–2.80)
Hysterectomy 0 (0%) 2 (2%) χ 
2 = 0.008, p = 0.928 1.25 (0.11–14.06)
Sedentary job 15 (29%) 41 (31%) χ 
2 = 0.047, p = 0.828 0.90 (0.45–1.79)
Average alcohol intake per
week (mL of pure ethanol) 4.97 ± 14.95 1.71 ± 10.04 t = 1.703, p = 0.090 N/A
Average weekly intake of
fermented milk products (mL) 1 793.92 ± 1 249.51 1 702.65 ±
3 141.97 t = 0.003, p = 0.998 N/A
Level of education (ґ ± SD)
high
middle
low
3 (6%)
32 (63%)
16 (31%)
17 (13%)
79 (60%)
36 (27%)
χ 
2 = 1.916, p = 0.384 N/A
No of irregular menstrual
cycles per year 1.6 ± 3.6 1.0 ± 2.4 t = 1.265, p = 0.207 N/A
Average duration of menstrual
bleeding (ґ ± SD) 5.04 ± 1.38 4.96 ± 1.75 t = 0.315, p = 0.754 N/A
Religion, n (%)
Christan 35 (69%) 94 (71%) χ 
2 = 3.490, p = 0.479 N/A
Muslim 2 (4%) 3 (2%)
Atheist 14 (27%) 14 (27%)
Results are presented as ґ ± SD, or n(%); *Significant difference; SE – standard error; N/A –not availableStrana 822 VOJNOSANITETSKI PREGLED Volumen 67, Broj 10
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There were no significant differences between the cases
and controls in: age; body mass index; existence of diabetes
mellitus type 1 or 2; systemic use of corticosteroids for at
least 15 days in the last 15 months; wearing of tight clothes
during 90% of time in the last year; predominant wearing of
underwear made from synthetic fabric; predominant wearing
of lace thong underwear during the last year; the use of im-
munosuppressive drugs for at least one month during the last
year; the presence of intrauterine contraceptive device during
at least 6 months in the last year; the rate of sexual inter-
courses during the last year; the use of hormonal contracep-
tives during at least 6 months before enrollment to the study;
exposure to training in vaginal irrigation offered by health
workers; smoking (more than 5 cigarettes daily during the
last year); bacteria in vaginal smear confirmed at least once
during the last year; concomitant chronic non-contagious
disease except for diabetes mellitus; serious event causing
stress during the last year (divorce, death of a first-line rela-
tive, loss of job or change of a city); concomitant hypothy-
reosis or hyperthyreosis; employment status; regular daily
intake of coffee during the last year; previous hysterectomy;
sedentary job during the last year; alcohol intake per week
during the last year; average weekly intake of fermented
milk products during the last year; the level of education;
number of irregular periods during the last year; average du-
ration of menstrual bleeding and religion (Christian, Muslim
or atheist).
The results of the logistic regression analysis with the
adjustment for potential confounders are shown in Table 2.
The only two significant associations were between recurrent
vulvovaginal candidiasis and continual wearing of panty lin-
ers during the last year (ORadjusted = 3.97; CI = 1.57–10.02; p
= 0.004), and between recurrent vulvovaginal candidiasis
and predominant use of vaginal tampons during menstruation
in the last year (ORadjusted  = 4.25; CI = 1.11–16.27; p =
0.035).  Although the crude odds ratios for antibiotic use
during seven or more days within the last month (OR = 1.97;
CI = 0.98–3.94) and self-medication with antimycotics (OR
= 1.95; CI = 1.00–3.83) were above one, and the difference
was significant (p = 0,049 and 0.044, respectively), after ad-
justment these odds ratios dropped to values close to one,
their CIs included 1, and the differences became statistically
not significant (p = 0.778 and 0.309, respectively).
The interactions between risk factors which are likely to
have an additive risk for recurrent vulvovaginal candidiasis
were investigated (Table 3). The analysis did not show a syn-
Table 2
Crude and adjusted odds ratios (OR) of the risk factors for recurrent vulvovaginal candidiasis
Risk factors Crude OR (95% CI) Adjusted* OR (95% CI)
Antibiotic use during seven or more days within the last month 1.97 (0.98–3.94) 1.17 (0.39–3.47)
Continual wearing of panty liners during the last year 3.23 (1.68–6.22) 3.97 (1.57–10.02)
Predominant use of vaginal tampons during menstruation in the last year 3.25 (1.24–8.50) 4.25 (1.11–16.27)
Self-medication with antimycotics 1.95 (1.00–3.83) 1.76 (0.59–5.23)
*Adjusted for age, body mass index, existence of diabetes mellitus type 1 or 2; antibiotic use during seven or more days within the last month; systemic use of corticosteroids for at least
15 days in the last 15 months; continual wearing of panty liners during the last year; wearing of tight clothes during 90% of time in the last year; predominant wearing of underwear
made from synthetic fabric; predominant wearing of lace thong underwear during the last year; predominant use of vaginal tampons during menstruation in the last year; use of
immunosuppressive drugs for at least one month during the last year; presence of intrauterine contraceptive device during at least 6 months in the last year; rate of sexual intercourses
during the last year; use of hormonal contraceptives during at least 6 months before enrollment to the study; exposure to training in vaginal irrigation offered by health workers;
smoking; bacteria in vaginal smear confirmed at least once during the last year; concomitant chronic non-contagious disease except diabetes mellitus; self-medication with antimycotics
(without being prescribed by a physician) during the last year; serious event causing stress during the last year; concomitant hypothyreosis or hyperthyreosis; employment status;
regular daily intake of coffee during the last year; previous hysterectomy; sedentary job during the last year; alcohol intake per week during the last year; average weekly intake of
fermented milk products during the last year; level of education; number of irregular periods during the last year; average duration of menstrual bleeding and religion.
CI – confidence interval.
Table 3
Interactions between the concurrent continual wearing of panty liners during the last year, predominant use of vaginal
tampons during menstruation in the last year, antibiotic use during seven or more days within the last month and
self-medication with antimycotics
Risk factors Crude odds ratio
(95% CI)
Adjusted* odds ratio
(95% CI)
Only antibiotic use during seven or more days within the last month
(A) 1.97 (0.98–3.94) 1.17 (0.39–3.47)
Only continual wearing of panty liners during the last year (B) 3.23 (1.68–6.22) 3.97 (1.57–10.02)
Only predominant use of vaginal tampons during menstruation in the
last year (C) 3.25 (1.24–8.50) 4.25 (1.11–16.27)
Only self-medication with antimycotics (D) 1.95 (1.00–3.83) 1.76 (0.59–5.23)
Both A and B 3.08 (1.32–7.16) 2.59 (0.74–9.07)
Both A and C 3.65 (0.79–16.91) 3.03 (0.35–26.23)
Both A and D 2.59 (1.11–6.04) 2.61 (0.83–8.21)
Both B and C 4.27 (1.16–15.75) 3.97 (0.78–20.17)
Both B and D
† 3.13 (1.35–7.28) 5.35 (1.57–18.28)
Both C and D 5.73 (1.38–23.80) 6.10 (0.90–41.40)
*Adjusted for age, body mass index, existence of diabetes mellitus type 1 or 2; antibiotic use during seven or more days within the last month; systemic use of corticosteroids for at least
15 days in the last 15 months; continual wearing of panty liners during the last year; wearing of tight clothes during 90% of time in the last year; predominant wearing of underwear
made from synthetic fabric; predominant wearing of lace thong underwear during the last year; predominant use of vaginal tampons during menstruation in the last year; use of
immunosuppressive drugs for at least one month during the last year; presence of intrauterine contraceptive device during at least 6 months in the last year; rate of sexual intercourses
during the last year; use of hormonal contraceptives during at least 6 months before enrollment to the study; exposure to training in vaginal irrigation offered by health workers;
smoking; bacteria in vaginal smear confirmed at least once during the last year; concomitant chronic non-contagious disease except diabetes mellitus; self-medication with antimycotics
(without being prescribed by a physician) during the last year; serious event causing stress during the last year; concomitant hypothyreosis or hyperthyreosis; employment status;
regular daily intake of coffee during the last year; previous hysterectomy; sedentary job during the last year; alcohol intake per week during the last year; average weekly intake of
fermented milk products during the last year; level of education; number of irregular periods during the last year; average duration of menstrual bleeding and religion.
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ergistic effect for: 1) the concurrent continual wearing of panty
liners during the last year and predominant use of vaginal tam-
pons during menstruation in the last year; 2) antibiotic use
during seven or more days within the last month and self-
medication with antimycotics; 3) predominant use of vaginal
tampons during menstruation in the last year and antibiotic use
during seven or more days within the last month; 4) predomi-
nant use of vaginal tampons during menstruation in the last
year and self-medication with antimycotics; 5) the concurrent
continual wearing of panty liners during the last year and anti-
biotic use during seven or more days within the last month.
After adjustment, the odds ratios either dropped down or their
confidence intervals included 1, and were not statistically sig-
nificant (p > 0.05). However, the synergistic effect was ob-
served for the concurrent continual wearing of panty liners
during the last year and self-medication with antimycotics: the
odds ratio increased to 5.35 (CI = 1.57–18.28), and was highly
statistically significant (p = 0.007).
Discussion
The results of our study did not confirm the results of
previous studies which identified factors like stress 
11, con-
sumption of acidophil-containing products, a history of bacte-
rial vaginosis, steroid therapy, diabetes mellitus, age <  40
years 
12, hormonal contraception, frequency of sexual inter-
courses and technique of vulvovaginal hygiene 
16 as predis-
posing for recurrent vulvovaginal candidiasis. However, con-
tinual wearing of panty liners during the last year emerged as
significant risk factor in our study, which is in accordance with
studies described by Sheary and Dayan 
12. Both this factor and
predominant use of vaginal tampons during menstruation
(which also has been significantly associated with recurrent
candidiasis in our study) could somehow promote growth of
Candida or break normal protective mechanisms of vaginal
mucosa, allowing invasion of the yeast and inflammation. Ac-
cording to the vaginal relapse theory 
19, female vagina is often
colonized with small numbers of yeast. If predisposing factors
are present, the yeast increases in number, invades mucosa and
causes a new clinical episode of vulvovaginal candidiasis. The
exact mechanism how these two local factors promote growth
or mucosal invasion of the yeast remains unclear, and needs to
be investigated.
It seems that systemic factors that decrease a host im-
mune defense are not important in pathogenesis of recurrent
vulvovaginal candidiasis: neither diabetes mellitus, systemic
use of corticosteroids, the use of immunosuppressants,
smoking, concomitant chronic non-contagious disease except
diabetes mellitus, serious event causing stress during the last
year nor concomitant hypothyreosis or hyperthyreosis were
associated with recurrent candidiasis in our study. Other
studies also did not find straightforward connection between
these systemic factors and recurrence of vulvovaginal dis-
ease 
20. At most, the systemic factors may assist to local risk
factors to break vaginal mucosal defense.
Although the emergence of increasingly resistant Can-
dida species does not seem to play a major part in recurrent
vulvovaginal candidiasis, women with recurrent disease do
have higher prevalence (10–15%) of Candida glabrata,
which is inherently less sensitive to the imidazole group of
drugs 
20, 21. In our study, self-medication with antimycotics,
as one of the causes of selection of resistant Candida species
19, 20, was not associated by itself with recurrent vulvovaginal
candidiasis. However, it interacts with the local risk factor
(wearing of panty liners), and increases likelihood of recur-
rence in women who already have this local risk factor (sig-
nificant increase in odds ratio – see Table 3). This means that
women who wear panty liners increase their chances to have
recurrent vulvovaginal candidiasis if they simultaneously
practice selfmedication with antimycotics. This interaction
suggests that clusters of risk factors could be more important
for the development of recurrent vulvovaginal candidiasis
than individual risk factors itself, which should be clarified
by further research.
Conclusion
Our study confirmed only two local factors identified
by previous studies (wearing of panty liners and the use of
tampons during menstruation) as important for recurrence of
vulvovaginal candidiasis, and showed that recurrence-
promoting effect of one of them (wearing of panty liners) is
augmented by the practice of self-medication with antimy-
cotics.
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